Scanning for melanoma

Summary Non-invasive diagnostic tools aim at increasing accuracy of melanoma diagnosis. Clinical naked eye observation in combination with dermoscopy can be regarded as the practical reference standard to identify lesions for histopathological evaluation. Pigmented lesions need to be evaluated in the context of patient history to identify risk factors for melanoma, followed by a dermoscopically-aided entire skin examination. Patients with identified risk factors should be further examined. Total body photography is widely used in the follow-up of high-risk patients (particularly those with numerous and dysplastic naevi) and can be coupled with digital dermoscopy or videodermoscopy. New noninvasive diagnostic aids comprise multispectral image analysis, reflectance confocal microscopy and computer assisted diagnostic systems. Also, molecular profiling of lesions is an emerging technique under investigation for melanoma diagnosis.

[1]  P. Aegerter,et al.  Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. , 2001, Archives of dermatology.

[2]  E. Smeraldi,et al.  Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline. , 2010, The Journal of clinical psychiatry.

[3]  H. Goldschmidt,et al.  Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patients , 2010, Bone Marrow Transplantation.

[4]  G. Feldman,et al.  Efficacy and safety of indacaterol 150 μg once-daily in COPD: a double-blind, randomised, 12-week study , 2010, BMC pulmonary medicine.

[5]  H. Haenssle,et al.  Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors. , 2010, Archives of dermatology.

[6]  S. Menzies,et al.  Impact of dermoscopy and short‐term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial , 2009, The British journal of dermatology.

[7]  S. Menzies,et al.  Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta‐analysis of studies performed in a clinical setting , 2008, The British journal of dermatology.

[8]  A. Nademanee,et al.  Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  C. Longo,et al.  The impact of in vivo reflectance confocal microscopy for the diagnostic accuracy of melanoma and equivocal melanocytic lesions. , 2007, The Journal of investigative dermatology.

[10]  H. Soyer,et al.  Teledermatology: how to start a new teaching and diagnostic era in medicine. , 2008, Dermatologic clinics.

[11]  H P Soyer,et al.  Dermoscopy of pigmented skin lesions--a valuable tool for early diagnosis of melanoma. , 2001, The Lancet. Oncology.

[12]  S. Kasper,et al.  Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder. , 2007, The international journal of neuropsychopharmacology.

[13]  S. Menzies,et al.  Accuracy of computer diagnosis of melanoma: a quantitative meta-analysis. , 2003, Archives of dermatology.